KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025.

“We’re excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our impact on children’s lives,” said Mark Throdahl, Executive Chairman of the OrthoPediatrics Board of Directors. “At the same time, we extend our deepest appreciation to Terry for over fifteen years of leadership as a Director and Chairman of the Board. His unwavering service and dedication to the Company, along with his insight and guidance, have been instrumental in establishing OrthoPediatrics as a pioneer in the pediatric orthopedic space.”

OthoPediatrics’ newly appointed board member, Kelly Fischer, currently serves as the Senior Vice President and Chief Financial Officer of Cook Medical, a multibillion dollar medical device company. For over two decades at Cook Medical, Ms. Fischer has held roles of increasing responsibility in finance and operations. Prior to joining Cook Medical, Ms. Fischer was an Audit Manager at Ernst & Young and held various positions at Arthur Andersen. Ms. Fischer holds a bachelor’s degree in accounting from  the Kelley School of Business at Indiana University.

“I am honored to join the OrthoPediatrics Board of Directors. The Company has demonstrated a steadfast commitment to the pediatric orthopedic field where it has advanced the standard of care since its inception,” said Kelly Fischer. “Leveraging my experience in the medical device industry, I am excited to support the strategy to help more kids by taking market share, launching new technologies and expanding the specialty bracing franchise in a capital efficient manner. It is a privilege to work alongside this talented team as we advanced towards helping one million kids.”

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit . For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit .

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
25/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results

OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results Increased Third Quarter 2025 Revenue 12% Year-over-year, and Increased Adjusted EBITDA by 56% year-over-year WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights       Helped over 37,000 children in the third quarter of 2025 and approximat...

 PRESS RELEASE

OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating ...

OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the FDA approval of its 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family. This represents the company’s 6th FDA approval in 2025. The 3P Small-Mini System is a versatile plate and s...

 PRESS RELEASE

OrthoPediatrics Corp. to Report Third Quarter Financial Results on Oct...

OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025 WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2025 financial results on October 28, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 28, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference ...

 PRESS RELEASE

OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue...

OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the third quarter ended September 30, 2025, and revised 2025 financial guidance. Preliminary Third Quarter 2025 Results...

 PRESS RELEASE

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spin...

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”). Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Wa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch